Clinical Trial Update: A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon

View source ↗

Summary

A completed cohort study in Korean patients with chronic hepatitis B evaluating pegylated interferon therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Yonsei University | Conditions: Chronic Hepatitis B | Status: COMPLETED